000			01330 a2200397 4500
005			20250515163333.0
264		0	_c20100825
008			201008s 0 0 eng d
022			_a1365-2265
024	7		_a10.1111/j.1365-2265.2009.03581.x _2doi
040			_aNLM _beng _cNLM
100	1		_aOdvina, Clarita V
245	0	0	_aUnusual mid-shaft fractures during long-term bisphosphonate therapy. _h[electronic resource]
260			_bClinical endocrinology _cFeb 2010
300			_a161-8 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAlendronate _xadverse effects
650	0	4	_aBone Density Conservation Agents _xadverse effects
650	0	4	_aBone and Bones _xdrug effects
650	0	4	_aDiphosphonates _xadverse effects
650	0	4	_aEtidronic Acid _xadverse effects
650	0	4	_aFemale
650	0	4	_aFractures, Bone _xchemically induced
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aOsteoporosis _xdrug therapy
650	0	4	_aRisedronic Acid
700	1		_aLevy, Shiri
700	1		_aRao, Sudhir
700	1		_aZerwekh, Joseph E
700	1		_aRao, D S
773	0		_tClinical endocrinology _gvol. 72 _gno. 2 _gp. 161-8
856	4	0	_uhttps://doi.org/10.1111/j.1365-2265.2009.03581.x _zAvailable from publisher's website
999			_c18740597 _d18740597